Atlas Trials

Low dosE GlibENclamide in Diabetes Part A

Clinical trial NCT02830048 · COMPLETED

Trial details

NCT number
NCT02830048
Sponsor
University of Oxford
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2016-07-01
Primary completion
2017-03-09
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.